Quest Diagnostics gains from DIS growth, advanced diagnostics uptake and AI-driven efficiencies, though debt levels and healthcare reimbursement risks remain concerns.
Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday reported upbeat earnings for the first quarter on Tuesday.
On April 21, 2026, Quest Diagnostics Inc (DGX) shares rose 4.5% to a current price of $205.04. This move is part of a broader uptrend, with the stock experienci
Quest Diagnostics Incorporated (DGX) Q1 2026 Earnings Call Transcript
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DGX heads into Q1 earnings with steady growth expectations, but estimate cuts and a negative ESP could temper the outlook.
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
8 Knots Management LLC grew its position in Quest Diagnostics Incorporated (NYSE: DGX) by 56.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 275,344 shares of the medical research company's stock after purchasing an additional 98,806 shares during the period. Quest Diagnostics makes